HealthDay.com
Many Ineligible for Clinical Trial Could Benefit From Teclistamab for Multiple Myeloma
89 percent of 509 patients would have been ineligible for MajesTEC-1 trial; estimated median PFS was 5.8 months
AI Can Accurately Estimate Bone Mineral Density and Classify Osteoporosis
System uses plain lumbar anteroposterior X-ray image
FDA Sends Warning Letters to Companies Selling Illegal Opioid Compound
7-hydroxymitragynine is not approved for use as dietary supplement, food additive, or drug ingredient
No Risks Seen With Early Childhood Exposure to Aluminum-Adsorbed Vaccines
No significantly increased risks observed for autoimmune disorder, atopic or allergic disorder, neurodevelopmental disorder
FDA Approves Gardenia-Based Blue Dye for Use in Foods and Drinks
Most Major Ice Cream Brands Will Remove Synthetic Dyes by 2028
High Dietary Inflammatory Index Tied to Increased Prevalence of Eczema
Significant sex interaction observed, with stronger associations in the female group
ENDO: Sweeteners, Genetic Predisposition Independently Linked to Early Puberty
No significant interaction effects seen between genetic predisposition and sweetener intake for central precocious puberty risk
ENDO: Superior Weight Loss Seen With Tirzepatide and Menopausal Hormone Therapy Use
For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss
Atopic Dermatitis May Be Linked to Increased Risk for CKD
Association between AD and increased risk for chronic kidney disease seen for men and women and in all age groups
